A common metabolic abnormality in hyperglycemic individuals, dyslipidemia is strongly linked to an increased risk of cardiovascular illness. This study looked at how date cider vinegar and 5:2 intermittent fasting affected the lipid profile and metabolic indices of hyperglycemic patients

The target population was adults between the ages of 35 and 65 years who are receiving outpatient care at a hospital or clinic with a diagnosis of either mild to moderate hypertension, dyslipidemia or pre-diabetes. Once consent was given, participants were then be randomly assigned to receive the prescribed intervention or act as a control. The intervention period was 12 weeks.

Participants in the experimental groups received date cider vinegar supplementation, with one group additionally following the 5:2 intermittent fasting protocol. The control group received standard dietary advice without vinegar supplementation or fasting intervention. Participants were instructed to follow the assigned intervention daily according to the study protocol. Weekly follow-up visits were conducted to monitor dietary compliance, record self-reported adherence, and assess health outcomes including lipid profile, body weight,and blood pressure. Usual dietary intake was also monitored to ensure consistency and adherence to the intervention.

At baseline, nutritional assessment based on weight and height, BMI, waist circumference, blood pressure, fasting blood glucose, lipid panels (HDL, LDL, total cholesterol, triglycerides), and dietary intake analysis were done. After 12 weeks of intervention all the measurements that were done again to compare the results pre- and post-intervention.

Inclusion Criteria:

• The inclusion criterion was target adults with both gender aged 35-65 years.
• Adults with a diagnosis of mild to moderate hypertension
• Mild hypertension (140-159/90-99 mm Hg)
• Moderate hypertension (160-179/100-109 mm Hg)
• Adults having mild to moderate alterations in lipid profile
• Triglycerides: 150 to 499 mg/dL
• LDL-C levels: Mild Alteration (130 to 159 mg/dL) and Moderate Alteration (160 to 189 mg/dL)
• Adults with pre-diabetes (hbA1c= 5.6-6.4%) were used.
• Patients were solicited from hospital.

Exclusion Criteria:

• Any Lactating and pregnant women were not included.
• Any person allergic to citric acid.
• Adults suffering from critical health conditions, including cancer.